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Objectives. This prospective case-control study evaluated the
acute and long-term results of stent implantation preceded by
debulking of the plaque by means of directional coronary atherec-
tomy.
Background. In comparison with balloon angioplasty, intra-
coronary stenting produces a larger luminal diameter, maintains
artery patency and reduces the incidence of restenosis. Optimal
stent deployment is a pivotal factor for achieving the best results,
but the bulk of the atherosclerotic plaque opposes stent expansion
and may limit the success of the procedure. Debulking of the
plaque may provide a better milieu for optimal stent deployment.
Methods. Directional coronary atherectomy followed by a single
Palmaz-Schatz stent implantation was attempted in 100 patients.
The successes, complications and angiographic results of the
combined procedure were evaluated both acutely and during
follow-up. Matched patients undergoing successful Palmaz-
Schatz stent implantation alone during the same period served as
controls.
Results. Atherectomy followed by stent implantation was per-
formed in 94 patients with 98 lesions; periprocedural complica-
tions were observed in four cases. The stenosis diameter decreased
from 76 6 9% at baseline to 30 6 13% after atherectomy (p <
0.0001), and 5 6 9% after stent implantation (p < 0.0001); it
increased to 27 6 15% at 6-month angiography (p < 0.0001).
During the 14 6 10 months of follow-up, none of the patients died
or experienced myocardial infarction, but three patients under-
went target lesion revascularization. The patients undergoing
stent implantation alone achieved smaller acute gains, tended to
have a higher late lumen loss, had a higher restenosis rate (30.5%
vs. 6.8%, p < 0.0001) and showed a greater incidence of clinical
events during follow-up (p < 0.0001).
Conclusions. Debulking atherosclerotic lesions by means of
directional coronary atherectomy before stent implantation is a
safe procedure with a high success rate and a low incidence of
restenosis at follow-up.
(J Am Coll Cardiol 1998;32:1855–60)
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Elective stent implantation after percutaneous transluminal
coronary angioplasty, which seals the intimal flaps and de-
creases the elastic recoil of the vessel, is associated with a
substantial and immediate angiographic gain, and less chance
of restenosis than balloon angioplasty (1,2). Optimal stent
deployment using a high inflation pressure or guidance by
intravascular ultrasonography is now emerging as a pivotal
factor for achieving the best results with the lowest level of risk
(3).
The bulk of the atherosclerotic plaque is displaced but not
removed by balloon angioplasty, and may therefore limit
optimal stent expansion and the success of the procedure. By
removing the atherosclerotic plaque, directional coronary
atherectomy could provide the best anatomical conditions for
successful stent implantation. This prospective study was un-
dertaken to evaluate the acute and long-term results of com-
bining directional coronary atherectomy and stent implanta-
tion via a matched comparison with stent implantation alone.
Methods
Study population. Angina pectoris patients with objective
evidence of myocardial ischemia and a new focal atheroscle-
rotic lesion in a native coronary artery suitable for both
atherectomy and stent implantation were considered eligible to
enter the study. The specific angiographic criteria for enroll-
ment included $75% and ,100% stenosis of a proximal
nontortuous coronary artery, with a reference diameter of
.2.5 mm and a lesion length #15 mm.
Exclusion criteria. Patients were excluded if they had
suffered acute myocardial infarction in the territory supplied
by the target vessel, had an allergy or contraindication to
aspirin or ticlopidine, or had a history of bleeding diathesis,
coagulopathy or stroke. The angiographic criteria for exclusion
were the presence of diffuse disease, left main coronary artery
disease, or peripheral vascular disease precluding atherectomy
sheath insertion.
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Study protocol. The patients enrolled in the study under-
went directional coronary atherectomy followed by a single
Palmaz-Schatz stent implantation; they received standardized
medical therapy and were seen in the outpatient clinic after 1,
3, and 6 months for an interview, physical examination and
electrocardiogram (ECG). Follow-up coronary angiography
was prospectively scheduled at 6 months unless the recurrence
of angina dictated its use earlier; in the latter case, if no
definite restenosis was present, an attempt was made to obtain
a further angiogram at 6 months. When more than one
angiogram was available, the one that provided the longest
angiographic follow-up was used in the analysis.
The controls were patients with the same inclusion/
exclusion characteristics who underwent successful elective
single Palmaz-Schatz stent implantation during the same pe-
riod. The lesions were individually matched by vessel, lesion
location, preprocedural reference diameter and preprocedural
minimal lumen diameter. The coronary artery tree was subdi-
vided into 15 segments according to the American Heart
Association guidelines (4), and the lesions were matched
within each segment. The observed differences in the reference
and minimal lumen diameters between two pair lesions had to
be within the range of reproducibility of the quantitative
analysis system for lesion measurement (5,6). Anginal status
was also taken into account as an additional clinical character-
istic in order to refine the matching process, which was
performed by an independent physician. The controls were
enrolled at the time of the interventional procedure and then
prospectively followed-up in exactly the same manner—that is,
they were seen in the outpatient clinic after 1, 3, and 6 months
for an interview, physical examination and ECG. Follow-up
coronary angiography was prospectively scheduled at 6 months
unless the recurrence of angina dictated its use earlier.
The study was approved by the hospital’s Institutional
Review Board, and all of the patients gave their written
informed consent.
Directional coronary atherectomy followed by stent implan-
tation. Directional coronary atherectomy and stent implanta-
tion were performed according to standard clinical practice.
Briefly, after a 300-cm-long wire was positioned through the
lesion, the atherectomy device was directed over the guide wire
and positioned across the stenosis. The support balloon was
then inflated up to 1 atm. The cutter was retracted and the
balloon inflation pressure increased to a maximum of 3 atm.
The driving motor was activated and the rotating cutter slowly
advanced to cut and collect the protruding atherosclerotic
lesion in the collecting chamber located at the tip of the
catheter. After each pass, the balloon was deflated and either
removed or repositioned.
To obtain the maximum debulking of the lesion, the
operator made the initial cuts toward the eccentricity; subse-
quent cuts were then performed in other plaque-bearing
quadrants, with the inflation pressure being increased to a
maximum of 4 atm if needed so as to remove tissue without
causing vessel perforation. After four cuts, the angiographic
result was observed, the atherocath removed, the specimen
collected and, in the case of suboptimal results, the atherocath
was reintroduced to optimize the debulking. An average of
4.7 6 1.6 atherectomy cuts per lesion were performed and a
median of 6.2 mg (range 0.1 to 14.1 mg) of atherosclerotic
plaque were extracted.
Following atherectomy, the 15-mm Palmaz-Schatz stent was
deployed at the site of the removed atherosclerotic lesion by
inflating a balloon over which the collapsed stent was inserted
(bare stent), or by dilating a balloon catheter with a pre-
mounted stent protected by an outer sheath during the passage
to the target site (delivery system). The balloon was inflated
under high pressure (minimum 12 atm) to ensure full stent
expansion. Although an optimal angiographic result was
sought for each treated lesion, and the goal was a residual
stenosis of less than 20%, the procedure was considered
angiographically successful if the residual stenosis was ,50%.
Stent implantation in controls. Balloon angioplasty and
stent implantation were performed according to standard
clinical practice: after the lesion was predilated, the 15-mm
Palmaz-Schatz stent was deployed in the same way as that
described above. After stent implantation, the stented area was
often further dilated by means of standard balloon angioplasty;
once again, a residual stenosis of less than 20% was sought for
each treated lesion, although a residual stenosis of ,50% was
considered angiographically successful.
Pharmacological protocol. Both groups of patients re-
ceived aspirin (160 to 325 mg q.d.), and treatment with calcium
channel antagonists was initiated at least 24 h before the
procedure. During the procedure, patients received an initial
bolus injection of 10,000 IU of heparin supplemented as
needed in order to maintain an activated clotting time of more
than 300 s. Ticlopidine (250 mg b.i.d.) was started at the end of
the procedure; the heparin infusion was continued, maintain-
ing an activated partial thromboplastin time of between 60 to
85 s until 2 to 6 h before sheath removal the following morning.
The patients continued receiving calcium channel blockers,
aspirin and ticlopidine for 1 month, and then only calcium
channel blockers and aspirin until the 6-month follow-up
coronary angiography.
Clinical follow-up. After the follow-up angiography, both
patients and controls were contacted by the investigators every
6 months to assess their clinical status.
The clinical end points were death, nonfatal myocardial
infarction or the need for repeat revascularization of the target
lesion. Death was defined to include all deaths. Myocardial
infarction was defined as the occurrence of prolonged chest
pain with a new abnormal Q-wave, or persistent ST- or T-wave
changes, with an increase in creatine kinase (CK) level or MB
fraction (which were serially measured for 24 h after the
procedure) of more than three times the upper limit of normal.
Repeat revascularization of the target lesion was defined as
angioplasty or bypass surgery performed because of restenosis
in association with angina, objective evidence of myocardial
ischemia or both.
Angiographic analysis. The degree of stenosis was assessed
by means of quantitative coronary angiography on coronary
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angiograms obtained before and immediately after atherec-
tomy, immediately after stent implantation, and at the 6-month
follow-up examination; in the controls, the angiograms were
obtained before and immediately after angioplasty, immedi-
ately after stent implantation, and at the 6-month examina-
tions. Each vessel was filmed in multiple projections after the
administration of 200 mg of intracoronary nitroglycerin to
standardize the quantitative coronary angiography. Once the
projection that best showed the stenosis in its tightest view was
identified, this was used for all of the angiograms. Four
end-diastolic frames (one from each angiogram) were then
selected and loaded onto a digital angiographic computer
system. All of the images were analyzed using an automatic
quantitative coronary arteriography program, which has been
described in detail elsewhere (5). The analysis was carried out
by two experienced cardiologists who were blinded as to the
patient’s identity, outcome and the sequence of the film. Each
value represents the average of the two estimates.
Minimal lesion diameter (MLD) and the nearest normal
reference diameter (ND) were measured in millimeters (mm)
using the catheter as a scaling factor. The percent stenosis was
calculated as 100 (1-MLD/ND). The acute gain was defined as
the difference between the MLD after stent implantation and
at baseline. Restenosis was measured as both a continuous and
dichotomous variable: as a continuous measure, it was calcu-
lated as the difference between the MLD immediately after
stent implantation and at 6 months (late loss); the loss index,
defined as late loss divided by acute gain, was also calculated
(7). As a binary variable, it was defined as a postprocedural
stenosis of less than 50% increasing to more than 50% at
follow-up angiography. The intra- and interobserver variability
of the quantitative assessments of minimal lumen diameter
have been previously reported (5,6).
Statistical analysis. The comparisons were made by means
of the chi-square test for categorical data and the unpaired
t-test for continuous variables. Differences within the group
undergoing directional coronary atherectomy followed by stent
implantation were assessed by means of the one-way repeated
measure analysis of variance, with Scheffe’s procedures for
multiple comparisons. Differences were considered statistically
significant when the two-tailed p value was less than 0.05.
Results
The study population consisted of 100 patients, 12% of
all of the patients undergoing nonsurgical revascularization
at the Catheterization Laboratory of the Division of Cardi-
ology, IRCCS, Policlinico San Matteo, Pavia, Italy, during
Table 1. Baseline Clinical and Angiographic Characteristics
Atherectomy 1 Stent
(No. of Patients 5 100)
Angioplasty 1 Stent
(No. of Patients 5 94)
Male (%) 84 91
Mean age (yr) 55 6 9 57 6 9
Family history (%) 46 41
Diabetes (%) 13 18
Hypertension (%) 39 46
Hypercholesterolemia (%) 37 43
Current smoker (%) 52 60
Previous myocardial infarction (%) 43 53
Angina pectoris class (%)
CCS II 16 22
CCS III 29 23
CCS IV 55 55
No. of diseased vessels (%)
1 61 65
2 27 28
3 12 7
No. of lesions 5 104 No. of lesions 5 94
Target vessel (%)
Left anterior descending artery 77 77
Left circumflex artery 4 4
Right coronary artery 19 19
Lesion classification (%)
A 8 9
B1 38 32
B2 40 53
C 14 6
Thrombus (%) 10 7
Lesion length (mm) 11.9 6 4.3 11.3 6 3.9
Vessel caliber (mm) 3.12 6 0.46 3.11 6 0.56
CCS 5 Canadian Cardiovascular Society. There were no significant differences in any of the listed variables.
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the study period. The combined procedure of atherectomy
followed by stent implantation was successfully performed
in 90 patients and 94 lesions. The atherectomy procedure
was attempted but not performed in five patients because it
was not possible to insert the atherectomy sheath (two
patients, one of whom had vascular perforation of the iliac
artery followed by surgical repair), engage the left main
ostium with the guiding catheter (two patients), or pass
through the lesion with the atherocath (one patient). In one
patient, the atherectomy was successfully performed, but
not followed by stent implantation because the vessel diam-
eter turned out to be ,2.5 mm. In the remaining four
patients, all of whom underwent the combined procedure,
acute complications occurred: two experienced coronary
dissection during stent implantation in the proximal part of
the left anterior descending artery near to the left main
coronary artery and were referred for coronary bypass
grafting (one on an emergency basis and one electively); one
showed a no-reflow phenomenon after atherectomy that
persisted after stent implantation, and also developed an
acute non-Q-wave myocardial infarction; the fourth patient
had side-branch occlusion during stent implantation and
developed non-Q-wave myocardial infarction. The proce-
dure was considered successful in five patients who devel-
Table 2. Technical Features and Angiographic Results of the Successful Procedures
Atherectomy 1 Stent
(No. of Lesions 5 94)
Angioplasty 1 Stent
(No. of Lesions 5 94) p
Technical Features
Diameter of arterial sheath
7F 0 3
8F 0 88
9F 9 2 ,0.0001
10F 73 1
11F 12 0
Maximum atherocath size
6F 12
7F 64
7FGraft 18
Maximum balloon size
2.5 mm 1 0
3.0 mm 40 47
3.5 mm 45 43 NS
4.0 mm 6 4
4.5 mm 2 0
No. of inflations during stent
implantation
1.39 6 0.5 1.91 6 0.6 0.013
Maximum atm during stent
implantation (mm Hg)
13.1 6 2.2 14.9 6 2.1 0.02
Length of procedure (min) 73.5 6 30 69.5 6 18 NS
Length of fluoroscopy (min) 15.9 6 7.8 13.8 6 7.6 0.018
Amount of contrast medium (ml) 364 6 190 274 6 88 0.003
Angiographic Results
Minimal lesion diameter (mm)
before the procedure 0.79 6 0.32 0.80 6 0.34 NS
after the procedure 2.26 6 0.49* 2.0 6 0.59 0.049
after stent implantation 3.22 6 0.51† 3.02 6 0.58 0.029
at follow-up 2.38 6 0.77‡ 2.03 6 0.81 0.009
Percent diameter stenosis (%)
before the procedure 76 6 9 76 6 10 NS
after the procedure 30 6 13* 37 6 14 0.007
after stent implantation 5 6 9† 11 6 11 0.0002
at follow-up 27 6 15‡ 40 6 19 0.0017
Change in minimal luminal diameter
acute gain (mm) 2.43 6 0.55 2.2 6 0.56 0.031
late loss (mm) 0.82 6 0.67 1.04 6 0.71 NS
loss index 0.31 6 0.35 0.54 6 0.44 0.002
Restenosis rate (%) 6.8 30.5 0.0001
*p , 0.0001 vs. before the procedure; †p , 0.0001 vs. after the procedure; ‡p , 0.0001 vs. after stent implantation.
Six-month follow-up coronary angiography was performed in 84 patients (88 lesions) in the atherectomy 1 stent group,
and in 85 patients (85 lesions) in the stent-alone group.
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oped an increase in CK levels ,3 times the upper limit of
normal without clinical or angiographic complications.
The clinical and angiographic characteristics of the patients
who underwent successful atherectomy followed by stent im-
plantation are shown in Table 1. The procedural characteris-
tics, and the acute and long-term angiographic results of the
combined procedure, are shown in Table 2. Immediately after
atherectomy, there was an increase in MLD (p , 0.0001), and
a further significant increase was observed after stent implan-
tation (p , 0.0001). Follow-up coronary angiography, which
was completed in 84 patients (93%), showed a decrease in
MLD in comparison with after-stent implantation (p ,
0.0001). There was a concomitant reduction in the percent
stenosis diameter after atherectomy (p , 0.0001) with a
further significant reduction after stent implantation (p ,
0.0001). At follow-up, there was an increase in percent stenosis
diameter (p , 0.0001) and restenosis, defined as a binary
variable, was observed in 6 of the 87 lesions (6.8%).
During the follow-up, which lasted 14 6 10 months (Table
3), the patient who had undergone emergency bypass surgery
owing to left main coronary dissection died. None of the
patients experienced myocardial infarction. Six patients expe-
rienced a recurrence of angina and underwent angiography
before the scheduled 6 months: three had a restenosis and
underwent repeat target lesion revascularization; the other
three showed no angiographic evidence of restenosis, but
showed progression of atherosclerotic disease in other coro-
nary segments.
Atherectomy followed by stent implantation versus stent
implantation alone. There were no significant differences
between the cases and matched controls with regard to the
clinical and angiographic characteristics (Table 1). The fluo-
roscopy time (p 5 0.018) and the amount of radiographic
contrast media used (p 5 0.003) were greater in the cases than
in the controls, whereas both the number of balloon inflations
(p 5 0.013) and the inflation pressures (p 5 0.02) used during
stent implantation were higher in the stent-alone group (Table
2). Directional coronary atherectomy led to a significantly
larger MLD (p 5 0.049) and a lower percent stenosis diameter
(p 5 0.007) than did balloon angioplasty.
Following stent implantation, the differences in MLD (p 5
0.029) and percent stenosis diameter (p 5 0.0002) were even
more pronounced, the acute gain being greater in the group
treated with atherectomy followed by stent implantation (p 5
0.031). Follow-up coronary angiography, which was completed
in 85 patients (90%), showed that the minimal lesion diameter
was greater (p 5 0.009) and the percent stenosis diameter
smaller (p 5 0.0017) in the patients treated with the combina-
tion. The loss index was significantly lower (p 5 0.002) in the
patients treated with atherectomy plus stent, who also showed
a trend toward a less late lumen loss. Restenosis, defined as a
binary variable, was observed in 26 lesions (30.5%) in the
stent-alone group, significantly more than in the combination
group (p , 0.0001).
During the follow-up of the controls, which lasted a mean of
14 6 12 months (Table 3), one patient died, and three
experienced a myocardial infarction (one due to subacute
thrombosis 8 days after the procedure). Twenty-two patients
experienced the recurrence of anginal symptoms, 12 of whom
underwent angiography before the scheduled 6 months (nine
had a restenosis and underwent repeat target lesion revascu-
larization, and three patients with no angiographic evidence of
restenosis showed the progression of atherosclerotic disease in
other coronary segments). Six patients underwent repeat target
lesion revascularization after the 6-month follow-up coronary
angiography. The incidence of clinical events during follow-up
was higher in the stent-alone group (p , 0.0001).
Discussion
Optimal stent expansion in coronary arteries is obtained by
overcoming the resistance opposed by the vessel wall and the
bulk of the atherosclerotic plaque. The use of high inflation
pressures has proved to be helpful in overcoming these resis-
tances, thus facilitating optimal stent expansion (3). Another
possible means of further optimizing stent expansion may be to
reduce atherosclerotic plaque resistance by removing the
plaque itself. The present study was designed to test whether
stent implantation using a high inflation pressure, preceded by
the debulking of the atherosclerotic wall by means of direc-
tional coronary atherectomy, is a safe procedure and associ-
ated with better angiographic results.
Acute and long-term results of directional coronary
atherectomy followed by stent implantation. Our data show
that directional coronary atherectomy followed by stent im-
plantation leads to further improvement in the acute angio-
graphic results obtained by atherectomy alone. Preliminary
data suggest that newer mechanical devices may reduce the
Table 3. Long-Term Clinical Outcome
Atherectomy 1 Stent
(No. of Patients 5 100)
Angioplasty 1 Stent
(No. of Patients 5 94) p
Duration of follow-up 14 6 10 14 6 12 NS
Death 1 1
Myocardial infarction 0 3
Target lesion revascularization 3 15
bypass surgery 2 4
repeat PTCA 1 11
Any of the above (%) 4 (4) 19 (20) ,0.0001
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incidence of restenosis by providing better acute results than
those that can be achieved by means of balloon angioplasty.
Larger acute lumens appear to accommodate the expected
subsequent renarrowing better, and so the final treated coro-
nary channel is larger and less likely to obstruct flow (8).
Directional coronary atherectomy aimed at obtaining the best
achievable results by using associated balloon angioplasty has
been shown to lead to better long-term results than balloon
angioplasty alone (9,10).
The use of a stent after atherectomy proposed in the
present study is in keeping with the idea of obtaining the best
achievable acute results, and it has the advantages of reducing
the elastic recoil of the lesion, preventing stenosis remodeling
and take-up flaps, exposing less surface to proliferative stimuli,
and supporting some of the wall stress loading that would
otherwise enhance muscle cell growth. All of these advantages
may explain the very low incidence of restenosis and symptom
recurrence in our study: figures of 6.8% of restenosis and 3%
of target lesion revascularization are the lowest reported so far
even with a moderate debulking, such as the one performed in
the present study (average of 4.7 cuts with a median of 6.2 mg
of tissue extracted).
However, it should be noted that the combined procedures
could be successfully performed in only 90 of the 100 patients
in whom it was attempted and that five of these 90 patients
developed an increase in CK level ,3 times the upper limit of
normal. Given the technical difficulties together with the
relatively high incidence of acute complications with the
combined procedures, large randomized trials aimed at dem-
onstrating an improved clinical outcome are needed before any
recommendation can be made.
Matched comparison with stent implantation. Although
the present study was not randomized, and therefore the
results of the group comparisons must be taken cautiously, it is
nevertheless interesting to note that the combination of
atherectomy plus stent implantation led to better angiographic
and clinical results than did stent implantation alone. The
incidence of restenosis in the stent-alone group was similar to
that observed in the STRESS trial (2) but higher than expected
in the era of optimal stent expansion. This may be related to
the high prevalence of unstable clinical conditions with com-
plex lesions involving predominantly proximal left anterior
descending coronary artery.
Not only did the combination achieve a larger immediate
gain (which intuitively translates into greater net angiographic
results after 6 months), it also had a significantly lower loss
index during follow-up. The reason why atherectomy followed
by stent implantation leads to a loss index that is lower than
either atherectomy (11,12) or stent implantation alone (1,2,13)
remains speculative. However, the combination of the two
favorable effects of a larger acute gain and a lower late lumen
loss may explain the exceptionally low incidence of restenosis
and the better clinical outcome observed in the group treated
with atherectomy followed by stent implantation.
Conclusions. Randomized trials that avoid selection bias
are needed to demonstrate whether the promising results
obtained in this pilot study are better than either optimal
atherectomy or optimal stent implantation alone. Future stud-
ies should particularly address the issue of the net clinical
benefit of combining directional coronary atherectomy and
stent implantation. The financial aspect of combining the
procedures should also be considered: the association of
atherectomy plus stent implantation is certainly more expen-
sive than either of the two techniques alone, but if the better
results obtained with the combined treatment lead to fewer
events and less need for repeated target lesion revasculariza-
tion and rehospitalization, it may be cost-effective.
Another possible approach that could exploit the beneficial
effects and contain the costs of the debulking strategy prior to
stent implantation may be to limit its use to those conditions in
which stent implantation alone is likely to fail. The identifica-
tion of the clinical or angiographic characteristics that would
benefit from the combination approach is therefore crucial and
needs to be addressed by future investigations.
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